BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 5, 2015
View Archived Issues
Prediction of tumor response to anti-PD-1 therapy in metastatic melanoma
Read More
Roche begins phase I study of RO-6927005 in solid tumors
Read More
Merck KGaA commences phase I trial of MSC-2490484A
Read More
First patient dosed in phase Ib trial of SYN-004 for the prevention of C. difficile infection
Read More
NephroGenex successfully completes QT study of Pyridorin
Read More
Warner Chilcott begins phase III study of sarecycline in acne vulgaris
Read More
Phase I study of intravenously administered BMS-986168 begins
Read More
GABA-A receptor modulation shows promising results for the treatment of autism spectrum disorders
Read More
Treatment ongoing in a phase I/II clinical trial of the antitumor RNAi therapeutic TKM-080301
Read More
Knight Therapeutics forms product commercialization partnership with NeurAxon
Read More
Preclinical investigation of a small-molecule JAK1/TYK2 inhibitor for psoriasis
Read More
MMP-3 may be a sex-specific marker of psychiatric disease
Read More
Researchers identify novel PS1 mutation involved in early-onset FAD
Read More
Shuttle Pharmaceuticals awarded NIH contract for novel radiation sensitizer in GI cancers
Read More
4D Pharma advances development of Blautix
Read More
United Therapeutics signs agreement with DEKA for development of Remodulin pump system
Read More
FDA approves trial protocol for Aethlon's Hemopurifier in patients infected with Ebola virus
Read More
Cempra reports results from phase III trial of solithromycin in bacterial pneumonia
Read More
Nav1.7 sodium channel blockers described in Amgen patents
Read More
Ferrer patents novel orexin OX2 receptor agonists
Read More
University of Texas System reports discovery of allosteric proteasome inhibitors
Read More
Antabio prepares and tests NDM-1 inhibitors for beta-lactam-resistant infections
Read More
Dual specificity protein kinase TTK inhibitors in early development at Bayer
Read More
Bristol-Myers Squibb identifies Factor VIIa inhibitors
Read More
Promising data revealed on rindopipemut for the treatment of relapsed glioblastoma
Read More